Regarding clinical phenotype, the onset occurs earlier in PD patients carrying a GBA1 mutation but the symptoms and efficacy of anti-PD medication is similar to those in idiopathic patients (Blanz and Saftig, 2016; Migdalska-Richards and Schapira, 2016; Aflaki et al., 2017). This evidence concerns the gene GBA1 and Parkinson disease.